Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
PLoS One ; 18(5): e0285736, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37220099

RESUMO

BACKGROUND: The response to the vaccine may vary among individuals. Hence, it is important to know how often individuals experience side effects after immunization against COVID-19. OBJECTIVE: This study aimed to assess the incidence of side effects following COVID-19 vaccination across different vaccine recipients in Southern Pakistan and identify the potential factors associated with these side effects in the population. METHODS: The survey was conducted across Pakistan through Google-forms Links from August to October 2021. The questionnaire included demographic information and COVID-19 vaccine information. Chi-square (x2) was performed for comparative analysis to check the significance level with P <0.05. The final analysis included 507 participants who had received COVID-19 vaccines. RESULTS: Of the total 507 COVID-19 vaccines recipients, 24.9% received CoronaVac, 36.5% received BBIBP-CorV, 14.2% received BNT162b2, 13.8% received AZD1222, and 10.7% received mRNA-1273. The most prominent side effects after the first dose were fever, weakness, lethargy, and pain at the site of injection. Moreover, the most commonly reported side effects after the second dose were pain at the injection site, headache, body ache, lethargy, fever, chills, flu-like symptoms, and diarrhea. CONCLUSION: Our results suggested that the side effects due to COVID-19 vaccination can vary between the first and second doses and type of COVID-19 vaccine. Our findings suggest continuing monitoring of vaccine safety and the importance of individualized risk-benefit assessment for COVID-19 immunization.


Assuntos
COVID-19 , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Vacinas , Humanos , Vacinas contra COVID-19 , Prevalência , Vacina BNT162 , ChAdOx1 nCoV-19 , Letargia , Paquistão , Febre
2.
Polymers (Basel) ; 14(18)2022 Sep 09.
Artigo em Inglês | MEDLINE | ID: mdl-36145914

RESUMO

The objective of this work was to formulate co-loaded bilayer tablets containing ezetimibe (EZB) and atorvastatin (ATC). ATC loaded in the immediate-release (IR) layer is an HMG CoA reductase inhibitor, while EZB, added in the sustained-release (SR) layer, is a lipid-lowering agent. This study was conducted to evaluate the effects of polymer on the formulation and characterization of bilayer tablets, as well as the therapeutic impact of the concurrent use of both drugs having a sequential release pattern. To obtain the optimized results, four different formulations with variable compositions were developed and evaluated for different parameters. The drug release studies were carried out using a type II dissolution apparatus, using phosphate buffer solution (PBS) of 1.2 pH for IR of EZB for an initial 2 h, followed by 24 h studies for ATC in PBS 6.8 pH. The IR layer showed rapid drug release (96%) in 2 h, while 80% of the ATC was released in 24 h from the SR layer. Locally obtained, 6-week-old female albino rats were selected for in vivo studies. Both preventive and curative models were applied to check the effects of the drug combination on the lipid profile, atherosclerosis and physiology of different organs. Studies have shown that the administration of both drugs with different release patterns has a better therapeutic effect (p < 0.05), both in preventing and in curing hyperlipidemia. Conclusively, through the sequential release of ATC and EZB, a better therapeutic response could be obtained.

3.
Vaccines (Basel) ; 11(1)2022 Dec 31.
Artigo em Inglês | MEDLINE | ID: mdl-36679942

RESUMO

This study aimed to explore knowledge, attitude, perceptions, and willingness regarding vaccination among university students in Pakistan. This cross-sectional study was carried out using an open online self-administered survey via Google Forms. The survey data were collected between the 15 to 30 of October 2022. A total of 946 respondents participated in the study, of which the majority were female (514, 54.3%). Most students belonged to a medical background, specifically pharmaceutical sciences. Most of the respondents did not know about monkeypox before 2022 (646, 68.3%). Regarding overall knowledge of monkeypox, most of the respondents had average knowledge (726, 76.7%), with very few having good knowledge (60, 6.3%). Regarding overall attitudes towards monkeypox, most of the respondents had neutral attitudes (648, 68.5%). There was a significant association between knowledge of Monkeypox with the type of academic degree (p < 0.001), type of discipline (p < 0.001), and region of respondents (p < 0.001). The willingness to vaccinate among the population was (67.7%). The current study pointed out that the overall knowledge of monkeypox was average in most respondents, with considerable knowledge gaps in most aspects. The overall attitude towards monkeypox was neutral. Further, the knowledge about monkeypox was strongly associated with academic degree, study discipline, and region of respondents. Our findings emphasize the need to raise public awareness by educating students on the monkeypox virus. This will improve adherence to preventative recommendations.

4.
J Multidiscip Healthc ; 14: 1267-1273, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34103927

RESUMO

BACKGROUND: Studies documented the important role of health-care professionals in encouraging their patients to adopt and use mobile health applications. Health-care professionals who use and believe in mobile health applications are more likely to encourage and empower their patients to use it. Likewise, students in health-profession related specialties who use mobile health applications are more likely to continue to do so when they join the workforce. OBJECTIVE: The objective of this study was to examine the rate of adoption of mobile health applications in students in health colleges, identify the types of health applications used by health students, and identify the barriers that prevent the use of mobile health applications. METHODS: A descriptive cross-sectional study was conducted among university students. Students were invited to participate in a self-administrated survey from five health colleges. The survey included questions about the pattern of utilization, the purpose of the health-related application being used, and the barriers to adoption. The analysis included descriptive statistics using SPSS. RESULTS: A total of 383 students participated in this study. The within gender comparison showed that more female students were using health-related applications 59.8% compared to male students 49%. The most frequent purpose of using mobile health applications were tracking physical activities 72.5% followed by counting calories intake 44%. We also identified the frequency and duration of use as well as the factors which may impact students intention to use. CONCLUSION: Fitness and dietary related applications were more common which might be explained by the fact that we only included a younger age group. The reported levels of perceived usefulness, accessibility and ease of use suggest that students will continue to use it.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...